Immunocytochemical Localization of Receptors Using Light and Confocal Microscopy With Application to the Phenotypic Characterization of Knock-Out Mice

  • Anthony P. Davenport
  • Rhoda E. Kuc
Part of the Methods in Molecular Biology™ book series (MIMB, volume 306)


This chapter describes the immunocytochemical (ICC) localization of receptors in tissue sections and cells growing in culture. The protocol is illustrated using examples of how site-directed polyclonal antisera can be used to distinguish between subtypes of G protein-coupled receptors (GPCRs; endothelin ETA and ETB), (1) in sections of human tissue or whole-body sections of mice, as well as mapping previously designated orphan receptors (oGPCR) recently paired with their cognate ligand illustrated by visualizing receptors for the peptide ghrelin (2). The methods are applicable to other receptor families.


Alexa Fluor Primary Antiserum Secondary Antiserum Swine Serum Nonspecific Background Staining 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Davenport, A. P. (2002) International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol. Rev. 54, 219–226.PubMedCrossRefGoogle Scholar
  2. 2.
    Katugampola, S., and Davenport, A. P. (2003) Emerging roles for orphan Gprotein-coupled receptors in the cardiovascular system. Trends Pharmacol. Sci. 24, 30–35.PubMedCrossRefGoogle Scholar
  3. 3.
    Katugampola, S. D., Pallikaros, Z., and Davenport, A. P. (2001) [125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with atherosclerosis. Br. J. Pharmacol. 134, 143–149.PubMedCrossRefGoogle Scholar
  4. 4.
    Davenport, A. P. (2003) Peptide and trace amine orphan receptors: prospects for new therapeutic targets. Curr. Opin Pharmacol. 3, 127–134.PubMedCrossRefGoogle Scholar
  5. 5.
    Davenport, A. P., and Macphee, C. H. (2003) Translating the human genome: Renaissance of cardiovascular receptor pharmacology. Curr. Opin. Pharmacol. 3, 111–113.PubMedCrossRefGoogle Scholar
  6. 6.
    Davenport, A. P. and Morton, A. J. (1991) Binding sites for 125IET-1, ET-2, ET-3 and vasoactive intestinal contractor are present in adult rat brain and neurone-enriched primary cultures of embryonic brain cells. Brain Res. 554, 278–285.PubMedCrossRefGoogle Scholar
  7. 7.
    Russell, F. D., Skepper, J. N., and Davenport, A. P. (1997) Detection of endothelin receptors in human coronary artery vascular smooth muscle cells but not endothelial cells by using electron microscope autoradiography. J. Cardiovasc.Pharmacol. 29, 820–826.PubMedCrossRefGoogle Scholar
  8. 8.
    Kuc, R. E. and Davenport, A. P. (2004) Comparison of ETA and ETB receptor distribution visualised by radioligand binding versus immunocytochemical localisation using sub-type selective antisera. J. Cardiovasc. Pharmacol. 43, S224–S226.CrossRefGoogle Scholar
  9. 9.
    Baker, S. J., Morris, J. L., and Gibbins, I. L. (2003) Cloning of a C-terminally truncated NK-1 receptor from guinea-pig nervous system. Brain. Res. Mol. Brain Res. 111, 136–147.PubMedCrossRefGoogle Scholar
  10. 10.
    Oliver, K. R., Wainwright, A., Edvinsson, L., Pickard, J. D., and Hill, R.G. (2002) Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature. J. Cereb. Blood Flow Metab. 22, 620–629.PubMedCrossRefGoogle Scholar
  11. 11.
    Robas, N., O'Reilly, M., Katugampola, S., and Fidock, M. (2003) Maximizing serendipity: strategies for identifying ligands for orphan G-protein-coupled receptors. Curr. Opin. Pharmacol. 3, 121–126.PubMedCrossRefGoogle Scholar
  12. 12.
    D'Orleans-Juste, P., Honore, J.-C., Carrier, E., and Labonte, J. (2003) Cardiovascular diseases: new insights from knockout mice. Curr. Opin. Pharmacol. 3, 181–185.PubMedCrossRefGoogle Scholar
  13. 13.
    Kurihara, H., Kurihara, J., and Yazaki, Y. (2001) Lessons from gene deletion of endothelin systems. Hdbk. Exp. Pharmacol. 152, 141–154.Google Scholar
  14. 14.
    Davenport, A. P., Kuc, R. E., Plumpton, C., Mockridge, J. W., Barker, P. J., and Huskisson, N. S. (1998). Endothelin-converting enzyme (ECE) in human tissue. Histochem. J., 30, 1–16.CrossRefGoogle Scholar
  15. 15.
    Davenport, A. P. and Kuc, R. E. (2000) Cellular expression of isoforms of endothelin-converting enzyme-1 (ECE-1 c, ECE-1 b and ECE-1 a) and endothelinconverting enzyme-2. J. Cardiovasc. Pharmacol. 36, S12–S14.PubMedGoogle Scholar
  16. 16.
    Kuc, R. E. Immunocytochemical localization of endothelin peptides, precursors and endothelin-converting enzymes. Methods Mol. Biol. 206, 3–9.Google Scholar

Copyright information

© Humana Press Inc. 2005

Authors and Affiliations

  • Anthony P. Davenport
    • 1
  • Rhoda E. Kuc
    • 1
  1. 1.Clinical Pharmacology UnitUniversity of Cambridge, Centre for Clinical Investigation, Addenbrooke’s HospitalCambridgeUK

Personalised recommendations